The global umbilical cord blood banking market is experiencing significant growth, driven by increasing awareness about the potential of cord blood stem cells in treating various diseases, advancements in banking technologies, and rising demand for regenerative medicine. Cord blood, rich in hematopoietic stem cells, is increasingly being used in medical treatments for conditions like leukemia, anemia, and other immune system disorders. The growing trend of private cord blood banking for personal use, as well as public banks for wider accessibility, is helping to fuel market growth. The market is further accelerated by technological advancements in cryopreservation methods, ensuring longer storage periods without compromising the integrity of the stem cells.
